Mark Emkjer Appointed to the Board of Directors of Hooper Holmes
February 05 2015 - 9:00AM
Business Wire
Hooper Holmes (NYSE MKT: HH) has appointed Mark J. Emkjer, a
senior healthcare executive with over 30 years of experience in the
provider, health plan and life sciences sectors, to the Company’s
Board of Directors effective February 1, 2015.
Ronald V. Aprahamian, Chairman of Hooper Holmes, commented,
“Mark has a track record of developing and implementing strategies
to improve business performance and help companies grow. We look
forward to working with him to continue building long-term
shareholder value.”
Mark Emkjer commented, “Wellness is a dynamic and growing
industry, and I am pleased to bring my strategic, operations and
healthcare experience to the Hooper Holmes Board.”
Mr. Emkjer most recently served as Chief Executive Officer of
the Health Services Division of WebMD from April 2009 to February
2014. Prior to joining WebMD he served as CEO, President and Board
Member of Accelrys, Inc., a software company serving the
pharmaceutical and biotech industries. Before Accelrys, Mr. Emkjer
was President and Chief Operating Officer of Sunquest, a leading
provider of clinical data management services. Prior to Sunquest he
served as President and CEO of Pace Health Management Systems,
Inc., and President and CEO of Hospital Cost Consultants Inc., a
leading international provider of financial solutions to the
healthcare industry. He began his career in a series of operating
roles at American Hospital Supply.
Mr. Emkjer holds a Master of Business Administration degree in
International Finance from the University of Miami and a Bachelor
of Science degree from Florida Atlantic University.
About Hooper Holmes
Hooper Holmes, Inc. mobilizes a national network of health
professionals to provide on-site health screenings, laboratory
testing, risk assessment and sample collection services to wellness
and disease management companies, insurance companies, employers,
government organizations and academic institutions.
This press release contains “forward-looking” statements; as
such term is defined in the Private Securities Litigation Reform
Act of 1995. These forward-looking statements are based on the
Company’s current expectations and beliefs and are subject to a
number of risks, uncertainties and assumptions. Among the important
factors that could cause actual results to differ materially from
those expressed in, or implied by, these forward-looking statements
are our ability to realize the expected benefits from our strategic
alliance with Clinical Reference Laboratory; our ability to
successfully implement our business strategy; our ability to retain
and grow our customer base; our ability to recognize operational
efficiencies and reduce costs; uncertainty as to our working
capital requirements over the next 12 to 24 months; our ability to
maintain compliance with the financial covenant in our credit
facility; and the rate of growth in the Health and Wellness market.
Additional information about these and other factors that could
affect the Company’s business is set forth in the Company’s annual
report on Form 10-K for the year ended December 31, 2013, filed
with the Securities and Exchange Commission on March 31, 2014. The
Company undertakes no obligation to update or release any revisions
to these forward-looking statements to reflect events or
circumstances after the date of this press release to reflect the
occurrence of unanticipated events, except as required by law.
Hooper HolmesHenry E. Dubois, President and CEO,
913-764-1045ORInvestors:S.M. Berger & CompanyAndrew Berger,
216-464-6400